Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07828405) titled 'Genes, Soy Isoflavones, and Virus' on Sept. 14.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
Condition:
Wheezing
Intervention:
Drug: Soy Isoflavone Nutritional Supplements
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: October 1, 2026
Target Sample Size: 60
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07828405
Disclaimer: ...